🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
After introducing intravenous erythropoietin (EPO) as an option for treatme...
Status
Completed
Location
Iran University of Medical Sciences
Start Date
2018-01-06
Trial ID
NCT03308448
Treatments Being Tested
This Phase 3 study in hemodialysis-dependent subjects with anemia will eval...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-09-05
Trial ID
NCT03400033
Treatments Being Tested
The purpose of this study is to compare the time to hematopoietic response ...
Status
Completed
Location
Multiple Locations
Start Date
2003-02
Trial ID
NCT00111137
Treatments Being Tested
This clinical trial aims at preventing visual dysfunction and optic nerve d...
Status
Completed
Location
Medical Center - University of Freiburg, Eye Hospital
Start Date
2014-11-25
Trial ID
NCT01962571
Treatments Being Tested
The purpose of this study is to determine the safety and effectiveness of e...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00270023
Treatments Being Tested
The purpose of this study is to investigate the relationship of anti-erythr...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT00211042
Treatments Being Tested
The purpose of this study is to assess the presence of anti erythropoietin ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT00210977
Treatments Being Tested
Open-label, randomized study of NESP in pediatric subjects 18 years of age ...
Status
Completed
Location
Multiple Locations
Start Date
2000-08
Trial ID
NCT00527137
Treatments Being Tested
Cumulative follow-up with HX575 epoetin alfa to prospectively monitor the i...
Status
Completed
Location
Dialysepraxis Dres. Huspek/Schmid
Start Date
2008-07
Trial ID
NCT00632125
Treatments Being Tested
Phase III, multicentre, double-blind, randomised, parallel, equivalence cli...
Status
Not Yet Recruiting
Location
Megalabs
Start Date
2025-07
Trial ID
NCT06352138